Pharma Equity Group A/S ("PEG” or the "Company”) hereby provides a strategic update regarding the Company’s revenue expectations, the development of the pipeline projects RNX-051 and RNX-011, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback